CDTX vs CPT · rev $1.3M vs P/E 104, rev $7.1M
Cidara Therapeutics Inc (CDTX) versus Camden Property Trust (CPT) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported CPT revenue for 2024-12-31 was $7.1M. Net income was $170.8M. Revenue was up 106.8% from 2023-12-31 to 2024-12-31. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
CDTX currently screens at market cap $6.96B. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Not investment advice. Open the CDTX and CPT stock pages for the full models.
Not investment advice.